{"entity":{"id":"nct02174549","kind":"trial","name":"Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer","aka":[],"tldr":"A phase 1/2 trial of Tirapazamine in hepatocellular carcinoma and neuroendocrine tumours, run by Teclison Ltd., now recruiting.","summary":"Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer is a phase 1/2 interventional study registered as NCT02174549 by Teclison Ltd., with 25 participants planned, started 2014-09 and due to reach its primary completion in 2028-03-31. Interventions recorded: Tirapazamine and Conventional Transarterial Embolization (TAE).","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT02174549","url":"https://clinicaltrials.gov/study/NCT02174549"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["hcc","neuroendocrine"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["teclison"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT02174549","phase":"1/2","setting":"Phase I Dose-Escalating Study of Combining Intravenous Tirapazamine and Transarterial Embolization (TAE) in Liver Cancer","sponsor":"Teclison Ltd.","participation":[{"nct":"NCT02174549","source":"https://clinicaltrials.gov/study/NCT02174549","fetchedAt":"2026-10-07T16:52:40.939Z","studySha256":"c79215734b55ff37808550236c75393e8a4f3e0274492d779d70e28c9fa94d61","overallStatus":"RECRUITING","lastUpdatePosted":"2026-04-20","leadSponsor":"Teclison Ltd.","collaboratorCount":0,"minimumAge":"20 Years","maximumAge":"99 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":25,"enrolmentType":"ESTIMATED","siteCount":2,"recruitingSiteCount":2,"countries":["United States"]}],"started":"2014-09","enrolled":25,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct02174549/","neighbours":{"cancer":[{"id":"hcc","kind":"cancer","name":"Hepatocellular carcinoma","route":"/cancers/hcc/"},{"id":"neuroendocrine","kind":"cancer","name":"Neuroendocrine tumours","route":"/cancers/neuroendocrine/"}],"company":[{"id":"teclison","kind":"company","name":"Teclison","route":"/companies/teclison/"}]}}